Eur Rev Med Pharmacol Sci 2020; 24 (21): 11192-11198

DOI: 10.26355/eurrev_202011_23607

MiR-133b inhibits MPP+-induced apoptosis in Parkinson’s disease model by inhibiting the ERK1/2 signaling pathway

L.-G. Dong, F.-F. Lu, J. Zu, W. Zhang, C.-Y. Xu, G.-L. Jin, X.-X. Yang, Q.-H. Xiao, C.-C. Cui, R. Xu, S. Zhou, J.-N. Zhu, T. Shen, G.-Y. Cui

Department of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. cuiguiyun-js@163.com


OBJECTIVE: The aim of this study was to explore the effect of micro ribonucleic acid (miR)-133b on 1-methyl-4-phenylpyridinium ion (MPP+)-induced apoptosis in the Parkinson’s disease (PD) model.

MATERIALS AND METHODS: PC12 cells were induced by different concentrations of MPP+ to establish the PD cell model. Subsequently, the survival rate of PC12 cells was detected using Cell Counting Kit-8 (CCK-8) assay. Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was used to detect the expression of miR-133b in the PD model induced by different concentrations of MPP+. Next, PC12 cells were transfected with miR-133b mimic and miR-negative control (NC), and divided into MPP+ group, MPP+ + miR-NC group and MPP+ + miR-133b mimic group. Transfection efficiency was verified using qRT-PCR. The apoptosis of cells was detected using terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay. Moreover, the expressions of extracellular signal-regulated kinase 1/2 (ERK1/2) and phosphorylated (p)-ERK1/2 were determined using Western blotting.

RESULTS: After MPP+ treatment, the survival rate of PC12 cells significantly declined (p<0.05). MPP+ exhibited toxicity against PC12 cells in a concentration-dependent manner. Meanwhile, cell survival rate decreased remarkably with the increase of MPP+ concentration (p<0.05). With increased concentration of MPP+, the expression of miR-133b in the PD cell model declined significantly (p<0.05). The apoptosis of PC12 cells was remarkably inhibited by overexpression of miR-133b in the PD cell model (p<0.05). In addition, the protein expression of p-ERK1/2 in PC12 cells was notably reduced after overexpression of miR-133b in the PD cell model (p<0.05).

CONCLUSIONS: MiR-133b is lowly expressed in the PD cell model. Furthermore, overexpression of miR-133b inhibits cell apoptosis in the PD cell model by regulating the ERK1/2 signaling pathway.

 

Free PDF Download

To cite this article

L.-G. Dong, F.-F. Lu, J. Zu, W. Zhang, C.-Y. Xu, G.-L. Jin, X.-X. Yang, Q.-H. Xiao, C.-C. Cui, R. Xu, S. Zhou, J.-N. Zhu, T. Shen, G.-Y. Cui
MiR-133b inhibits MPP+-induced apoptosis in Parkinson’s disease model by inhibiting the ERK1/2 signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 21
Pages: 11192-11198
DOI: 10.26355/eurrev_202011_23607